相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Is There a Role for Fatty Acid Synthase in the Diagnosis of Prostatic Adenocarcinoma? A Comparison With AMACR
Xiaojun Wu et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2011)
The Utility of ERG/P63 Double Immunohistochemical Staining in the Diagnosis of Limited Cancer in Prostate Needle Biopsies
Oksana Yaskiv et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2011)
Immunohistochemistry for ERG Expression as a Surrogate for TMPRSS2-ERG Fusion Detection in Prostatic Adenocarcinomas
Alcides Chaux et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2011)
The Diagnostic Utility of Novel Immunohistochemical Marker ERG in the Workup of Prostate Biopsies With Atypical Glands Suspicious for Cancer
Huiying He et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2011)
ERG Transcription Factor as an Immunohistochemical Marker for Vascular Endothelial Tumors and Prostatic Carcinoma
Markku Miettinen et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2011)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Molecular Predictors of Response to Therapy for Breast Cancer
Natalie Galanina et al.
CANCER JOURNAL (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
ERG Status Is Unrelated to PSA Recurrence in Radically Operated Prostate Cancer in the Absence of Antihormonal Therapy
Sarah Minner et al.
CLINICAL CANCER RESEARCH (2011)
Diagnostic utility of p63/P501S double sequential immunohistochemical staining in differentiating urothelial carcinoma from prostate carcinoma
Malini Srinivasan et al.
DIAGNOSTIC PATHOLOGY (2011)
Confirmation of the Association of TMPRSS2(exon 0):ERG Expression and a Favorable Prognosis of Primary Prostate Cancer
Joost L. Boormans et al.
EUROPEAN UROLOGY (2011)
Epigenetics in Prostate Cancer: Biologic and Clinical Relevance
Carmen Jeronimo et al.
EUROPEAN UROLOGY (2011)
Relevance of cohort design for studying the frequency of the ERG rearrangement in prostate cancer
Martin Braun et al.
HISTOPATHOLOGY (2011)
TMPRSS2-ERG gene fusion in small cell carcinoma of the prostate
Charles C. Guo et al.
HUMAN PATHOLOGY (2011)
Association of tissue promoter methylation levels of APC, TGFβ2, HOXD3 and RASSF1A with prostate cancer progression
Liyang Liu et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Androgen Receptor-Positive Salivary Duct Carcinoma: A Disease Entity With Promising New Treatment Options
Heidy C. J. Jaspers et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Prospective Multi-Institutional Study Evaluating the Performance of Prostate Cancer Risk Calculators
Robert K. Nam et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Protein-network modeling of prostate cancer gene signatures reveals essential pathways in disease recurrence
James L. Chen et al.
JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION (2011)
MicroRNA-100 Expression is Independently Related to Biochemical Recurrence of Prostate Cancer
Katia R. M. Leite et al.
JOURNAL OF UROLOGY (2011)
Antibody EPR3864 is specific for ERG genomic fusions in prostate cancer: implications for pathological practice
Geert J. L. H. van Leenders et al.
MODERN PATHOLOGY (2011)
Folate hydrolase (prostate-specific antigen) 1 expression in bladder cancer subtypes and associated tumor neovasculature
Mary K. Samplaski et al.
MODERN PATHOLOGY (2011)
ERG gene rearrangements are common in prostatic small cell carcinomas
Tamara L. Lotan et al.
MODERN PATHOLOGY (2011)
ERG-TMPRSS2 rearrangement is shared by concurrent prostatic adenocarcinoma and prostatic small cell carcinoma and absent in small cell carcinoma of the urinary bladder: evidence supporting monoclonal origin
Sean R. Williamson et al.
MODERN PATHOLOGY (2011)
Increased gene copy number of ERG on chromosome 21 but not TMPRSS2-ERG fusion predicts outcome in prostatic adenocarcinomas
Antoun Toubaji et al.
MODERN PATHOLOGY (2011)
Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study
Jack Cuzick et al.
LANCET ONCOLOGY (2011)
The genomic complexity of primary human prostate cancer
Michael F. Berger et al.
NATURE (2011)
A Tri-Marker Proliferation Index Predicts Biochemical Recurrence after Surgery for Prostate Cancer
Sameer Malhotra et al.
PLOS ONE (2011)
Androgen Receptors Are Differentially Expressed in Gleason Patterns of Prostate Cancer and Down-Regulated in Matched Lymph Node Metastases
Achim Fleischmann et al.
PROSTATE (2011)
TMPRSS2-ERG Gene Fusion Prevalence and Class Are Significantly Different in Prostate Cancer of Caucasian, African-American and Japanese Patients
Cristina Magi-Galluzzi et al.
PROSTATE (2011)
Diagnostic biomarkers of prostate cancer
Lars Haggarth et al.
SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY (2011)
ERG gene rearrangement status in prostate cancer detected by immunohistochemistry
Sara Moscovita Falzarano et al.
VIRCHOWS ARCHIV (2011)
NKX3.1 as a Marker of Prostatic Origin in Metastatic Tumors
Bora Gurel et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2010)
Molecular sampling of prostate cancer: a dilemma for predicting disease progression
Andrea Sboner et al.
BMC MEDICAL GENOMICS (2010)
Distinct Genomic Alterations in Prostate Cancers in Chinese and Western Populations Suggest Alternative Pathways of Prostate Carcinogenesis
Xueying Mao et al.
CANCER RESEARCH (2010)
Molecular predictive and prognostic markers in colon cancer
Thomas Winder et al.
CANCER TREATMENT REVIEWS (2010)
Prostate-specific antigen and hormone receptor expression in male and female breast carcinoma
Teresa S. Kraus et al.
DIAGNOSTIC PATHOLOGY (2010)
Comparison of the diagnostic value of fatty acid synthase (FASN) with alpha-methylacyl-CoA racemase (AMACR) as prostatic cancer tissue marker
Verena Tischler et al.
HISTOPATHOLOGY (2010)
ERG rearrangement in small cell prostatic and lung cancer
Veit J. Scheble et al.
HISTOPATHOLOGY (2010)
A study of indefinite for dysplasia in Barrett's oesophagus: reproducibility of diagnosis, clinical outcomes and predicting progression with AMACR (alpha-methylacyl-CoA-racemase)
Sunil A. Sonwalkar et al.
HISTOPATHOLOGY (2010)
Development of a Diagnostic Microarray Assay to Assess the Risk of Recurrence of Prostate Cancer Based on PITX2 DNA Methylation
Philipp Schatz et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2010)
Multicenter Clinical Validation of PITX2 Methylation as a Prostate Specific Antigen Recurrence Predictor in Patients With Post-Radical Prostatectomy Prostate Cancer
Lionel L. Banez et al.
JOURNAL OF UROLOGY (2010)
ETS family-associated gene fusions in Japanese prostate cancer: analysis of 194 radical prostatectomy samples
Yohei Miyagi et al.
MODERN PATHOLOGY (2010)
TMPRSS2-ERG gene fusion in transition zone prostate cancer
Tarek A. Bismar et al.
MODERN PATHOLOGY (2010)
ERG rearrangement is present in a subset of transition zone prostatic tumors
Sara M. Falzarano et al.
MODERN PATHOLOGY (2010)
ERG rearrangement is specific to prostate cancer and does not occur in any other common tumor
Veit J. Scheble et al.
MODERN PATHOLOGY (2010)
TMPRSS2-ERG gene fusion is associated with low Gleason scores and not with high-grade morphological features
Samson W. Fine et al.
MODERN PATHOLOGY (2010)
Prevalence of TMPRSS2-ERG and SLC45A3-ERG gene fusions in a large prostatectomy cohort
Raquel Esgueva et al.
MODERN PATHOLOGY (2010)
DNA methylation of HOXD3 as a marker of prostate cancer progression
Ken J. Kron et al.
LABORATORY INVESTIGATION (2010)
Immunohistochemical application of D2-40 as basal cell marker in evaluating atypical small acinar proliferation of initial routine prostatic needle biopsy materials
Naoto Kuroda et al.
MEDICAL MOLECULAR MORPHOLOGY (2010)
Expression of potential molecular markers in prostate cancer: Correlation with clinicopathological outcomes in patients undergoing radical prostatectomy
Hideaki Miyake et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2010)
ERG Rearrangement Metastasis Patterns in Locally Advanced Prostate Cancer
Sven Perner et al.
UROLOGY (2010)
Antibody-Based Detection of ERG Rearrangement-Positive Prostate Cancer
Kyung Park et al.
NEOPLASIA (2010)
Ki-67 and outcome in clinically localised prostate cancer: analysis of conservatively treated prostate cancer patients from the Trans-Atlantic Prostate Group study
D. M. Berney et al.
BRITISH JOURNAL OF CANCER (2009)
TMPRSS2-ERG Gene Fusion Is Not Associated with Outcome in Patients Treated by Prostatectomy
Anuradha Gopalan et al.
CANCER RESEARCH (2009)
Overexpression of Prostate-Specific TMPRSS2(exon 0)-ERG Fusion Transcripts Corresponds with Favorable Prognosis of Prostate Cancer
Karin G. Hermans et al.
CLINICAL CANCER RESEARCH (2009)
Critical review of prostate cancer predictive tools
Shahrokh F. Shariat et al.
FUTURE ONCOLOGY (2009)
Tumour growth fraction measured by immunohistochemical staining of Ki67 is an independent prognostic factor in preoperative prostate biopsies with small-volume or low-grade prostate cancer
Tobias Zellweger et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
MDM2 and Ki-67 Predict for Distant Metastasis and Mortality in Men Treated With Radiotherapy and Androgen Deprivation for Prostate Cancer: RTOG 92-02
Li-Yan Khor et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
MicroRNAs in Cancer: Small Molecules With a Huge Impact
Marilena V. Iorio et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Fatty Acid Synthase: A Metabolic Enzyme and Candidate Oncogene in Prostate Cancer
Toshiro Migita et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
DNA Methylation of the PITX2 Gene Promoter Region is a Strong independent Prognostic Marker of Biochemical Recurrence in Patients With Prostate Cancer After Radical Prostatectomy
Gunter Weiss et al.
JOURNAL OF UROLOGY (2009)
Prostate cancer of transition zone origin lacks TMPRSS2-ERG gene fusion
Charles C. Guo et al.
MODERN PATHOLOGY (2009)
ETS gene fusions in prostate cancer
Jeremy P. Clark et al.
NATURE REVIEWS UROLOGY (2009)
A single institution experience with biochemical recurrence after radical prostatectomy for tumors that on pathology are of small volume or insignificant
I. M. van Oort et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2009)
Immunohistochemical expression of prostatic antigens in adenocarcinoma and villous adenoma of the urinary bladder
Zhaoli Lane et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2008)
Partial atrophy on prostate needle biopsy cores: A morphologic and immunohistochemical study
Wenle Wang et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2008)
False Positive Labeling of Prostate Cancer With High Molecular Weight Cytokeratin: p63 a More Specific Immunomarker for Basal Cells
Tehmina Z. Ali et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2008)
Small cell carcinoma of the prostate - A morphologic and immunohistochemical study of 95 cases
Wenle Wang et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2008)
Aberrant diffuse expression of p63 in adenocarcinoma of the prostate on needle biopsy and radical prostatectomy: Report of 21 cases
Adeboye O. Osunkoya et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2008)
Association of TMPRSS2-ERG gene fusion with clinical characteristics and outcomes: results from a population-based study of prostate cancer
Liesel M. FitzGerald et al.
BMC CANCER (2008)
GOLPH2 protein expression as a novel tissue biomarker for prostate cancer:: implications for tissue-based diagnostics
G. Kristiansen et al.
BRITISH JOURNAL OF CANCER (2008)
The clinical management of patients with a small volume of prostatic cancer on biopsy: What are the risks of progression?
Patricia Harnden et al.
CANCER (2008)
Critical assessment of tools to predict clinically insignificant prostate cancer at radical prostatectomy in contemporary men
Felix K. -H. Chun et al.
CANCER (2008)
Active surveillance for early-stage prostate cancer - Review of the current literature
Marc A. Dall'Era et al.
CANCER (2008)
Nine-gene molecular signature is not associated with prostate cancer death in a watchful waiting cohort
Lorelei A. Mucci et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)
Testing a multigene signature of prostate cancer death in the Swedish Watchful Waiting Cohort
Lorelei A. Mucci et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)
Characterization of TMPRSS2-ERG fusion high-grade prostatic intraepithelial neoplasia and potential clinical implications
Juan-Miguel Mosquera et al.
CLINICAL CANCER RESEARCH (2008)
TMPRSS2:ERG fusion identifies a subgroup of prostate cancers with a favorable prognosis
Outi R. Saramaki et al.
CLINICAL CANCER RESEARCH (2008)
Validation of the Contemporary Epstein Criteria for Insignificant Prostate Cancer in European Men
Claudio Jeldres et al.
EUROPEAN UROLOGY (2008)
alpha-Methylacyl-CoA racemase - an 'obscure' metabolic enzyme takes centre stage
Matthew D. Lloyd et al.
FEBS JOURNAL (2008)
Prostatic adenocarcinoma in colorectal biopsy: clinical and pathologic features
Zhaoli Lane et al.
HUMAN PATHOLOGY (2008)
Absence of TMPRSS2:ERG fusions and PTEN losses in prostate cancer is associated with a favorable outcome
Maisa Yoshimoto et al.
MODERN PATHOLOGY (2008)
Overexpression of fatty acid synthase is associated with palmitoylation of Wnt1 and cytoplasmic stabilization of β-catenin in prostate cancer
Michelangelo Fiorentino et al.
LABORATORY INVESTIGATION (2008)
Assessment of somatic k-RAS mutations as a mechanism associated with resistance to EGFR-targeted agents:: a systematic review and meta-analysis of studies in advanced non-small-cell lung cancer and metastatic colorectal cancer
Helena Linardou et al.
LANCET ONCOLOGY (2008)
GOLPH2 and MYO6: Putative prostate cancer markers localized to the Golgi apparatus
Shuanzeng Wei et al.
PROSTATE (2008)
Active surveillance for favorable risk prostate cancer: What are the results, and how safe is it?
Laurence Klotz
SEMINARS IN RADIATION ONCOLOGY (2008)
Do Clinically Insignificant Tumors of the Prostate Exist?
K. Stamatiou et al.
UROLOGIA INTERNATIONALIS (2008)
Utility of bcl-2, p53, Ki-67, and caveolin-1 immunostaining in the prediction of biochemical failure after radical prostatectomy in a Japanese population
Takahiro Goto et al.
UROLOGY (2008)
Combined prostate-specific antigen density and biopsy features to predict Clinically Insignificant prostate cancer
Stacy Loeb et al.
UROLOGY (2008)
Ki67 staining index and neuroendocrine differentiation aggravate adverse prognostic parameters in prostate cancer and are characterized by negligible inter-observer variability
Sven Gunia et al.
WORLD JOURNAL OF UROLOGY (2008)
Golgi Protein GOLM1 Is a Tissue and Urine Biomarker of Prostate Cancer
Sooryanarayana Varambally et al.
NEOPLASIA (2008)
EZH2, Ki-67 and MCM7 are prognostic markers in prostatectomy treated patients
Sari Laitinen et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer
G. Attard et al.
ONCOGENE (2008)
After radical retropubic prostatectomy 'insignificant' prostate cancer has a risk of progression similar to low-risk 'significant' cancer
Shomik Sengupta et al.
BJU INTERNATIONAL (2008)
Expression of the TMPRSS2:ERG fusion gene predicts cancer recurrence after surgery for localised prostate cancer
R. K. Nam et al.
BRITISH JOURNAL OF CANCER (2007)
Cotorectal adenocarcinoma involving the prostate: report of 9 cases
Adeboye O. Osunkoya et al.
HUMAN PATHOLOGY (2007)
Active surveillance for favorable risk prostate cancer: Rationale, risks, and results
Laurence Klotz
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2007)
High promoter methylation levels of APC predict poor prognosis in sextant biopsies from prostate cancer patients
Rui Henrique et al.
CLINICAL CANCER RESEARCH (2007)
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis
Javier A. Menendez et al.
NATURE REVIEWS CANCER (2007)
Endosomal trafficking and proprotein convertase cleavage of cis Golgi protein GP73 produces marker for hepatocellular carcinoma
Collin Bachert et al.
TRAFFIC (2007)
Genomic profiling reveals alternative genetic pathways of prostate tumorigenesis
Jacques Lapointe et al.
CANCER RESEARCH (2007)
The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate
Todd Sheridan et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2007)
Immunohistochemical differentiation of high-grade prostate carcinoma from urothelial carcinoma
Ai-Ying Chuang et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2007)
TMPRSS2: ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort
F. Demichelis et al.
ONCOGENE (2007)
TMPRSS2-ERG fusion prostate cancer:: An early molecular event associated with invasion
Sven Perner et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2007)
Immunohistochemical antibody cocktail staining (p63/HMWCK/AMACR) of ductal adenocarcinoma and Gleason pattern 4 cribriform and noncribriform acinar adenocarcinomas of the prostate
Mehsati Herawi et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2007)
Morphological features of TMPRSS2-ERG gene fusion prostate cancer
J-M Mosquera et al.
JOURNAL OF PATHOLOGY (2007)
CD109, a new marker for myoepithelial cells of mammary, salivary, and lacrimal glands and prostate basal cells
Masaki Hasegawa et al.
PATHOLOGY INTERNATIONAL (2007)
Expression analysis of imbalanced genes in prostate carcinoma using tissue microarrays
I. Prowatke et al.
BRITISH JOURNAL OF CANCER (2007)
Heterogeneous expression of alpha-methylacyl-CoA racemase in prostatic cancer correlates with Gleason score
A. J. Murphy et al.
HISTOPATHOLOGY (2007)
Expression of TMPRSS2 ERG gene fusion in prostate cancer cells is an important prognostic factor for cancer progression
Robert K. Nam et al.
CANCER BIOLOGY & THERAPY (2007)
Complications, urinary continence, and oncologic outcome of 1000 laparoscopic transperitoneal radical prostatectomies - Experience at the Charite Hospital Berlin, Campus Mitte
Michael Lein et al.
EUROPEAN UROLOGY (2006)
Decreased NKX3.1 protein expression in focal prostatic atrophy, prostatic Intraepithelial neoplasia, and adenocarcinoma: Association with Gleason score and chromosome 8p deletion
Carlise R. Bethel et al.
CANCER RESEARCH (2006)
Abundant expression of AMACR in many distinct tumour types
Philip T. Went et al.
PATHOLOGY (2006)
TMPRSS2:: ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer
Sven Perner et al.
CANCER RESEARCH (2006)
Expression of variant TMPRSS2/ERG fusion messenger RNAs is associated with aggressive prostate cancer
Jianghua Wang et al.
CANCER RESEARCH (2006)
25-year prostate cancer control and survival outcomes: A 40-year radical prostatectomy single institution series
Christopher R. Porter et al.
JOURNAL OF UROLOGY (2006)
Long-term outcome following radical prostatectomy in men with clinical stage T3 prostate cancer
Brett S. Carver et al.
JOURNAL OF UROLOGY (2006)
AMACR immunostaining is useful in detecting dysplastic epithelium in Barrett's esophagus, ulcerative colitis, and Crohn's disease
Russell Dorer et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2006)
Detection of prostate cancer by α-methylacyl CoA racemase (P504S) in needle biopsy specimens previously reported as negative for malignancy
BM Carswell et al.
HISTOPATHOLOGY (2006)
Expression of prostate-specific membrane antigen in normal and malignant human tissues
Y Kinoshita et al.
WORLD JOURNAL OF SURGERY (2006)
Current practice of diagnosis and reporting of prostate cancer on needle biopsy among genitourinary pathologists
L Egevad et al.
HUMAN PATHOLOGY (2006)
Epithelial-restricted gene profile of primary cultures from human prostate tumors: A molecular approach to predict clinical behavior of prostate cancer
S Nanni et al.
MOLECULAR CANCER RESEARCH (2006)
Steroid hormone receptor expression in male breast cancer
CE Murphy et al.
EJSO (2006)
Defining aggressive prostate cancer using a 12-gene model
Tarek A. Bismar et al.
NEOPLASIA (2006)
GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma
JA Marrero et al.
JOURNAL OF HEPATOLOGY (2005)
Comparison of monoclonal antibody (P504S) and polyclonal antibody to alpha methylacyl-CoA racemase (AMACR) in the work-up of prostate cancer
LP Kunju et al.
HISTOPATHOLOGY (2005)
Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression
S Varambally et al.
CANCER CELL (2005)
Immunohistochemical expression of Ki-67 antigen, Cox-2 and Bax/Bcl-2 in prostate cancer;: Prognostic value in biopsies and radical prostatectomy specimens
J Rubio et al.
EUROPEAN UROLOGY (2005)
Age-associated changes in alpha-methyl CoA racemase (AMACR) expression in nonneoplastic prostatic tissues
A Gologan et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2005)
Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer
SA Tomlins et al.
SCIENCE (2005)
Small glandular proliferations on needle biopsies - Most common benign mimickers of prostatic adenocarcinoma sent in for expert second opinion
M Herawi et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2005)
Alpha-methylacyl-CoA racemase (AMACR) expression in normal prostatic glands and high-grade prostatic intraepithelial neoplasia (HGPIN): Association with diagnosis of prostate cancer
V Ananthanarayanan et al.
PROSTATE (2005)
20-year outcomes following conservative management of clinically localized prostate cancer
PC Albertsen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Expression profiling of microdissected matched prostate cancer samples reveals CD166/MEMD and CD24 as new prognostic markers for patient survival
G Kristiansen et al.
JOURNAL OF PATHOLOGY (2005)
Diagnosis and reporting of limited adenocarcinoma of the prostate on needle biopsy
JI Epstein
MODERN PATHOLOGY (2004)
How often does alpha-methylacyl-CoA-racemase contribute to resolving an atypical diagnosis on prostate needle biopsy beyond that provided by basal cell markers?
M Zhou et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2004)
Gene expression profiling identifies clinically relevant subtypes of prostate cancer
J Lapointe et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Utility of immunohistochemistry for α-methylacyl-CoA racemase in distinguishing atrophic prostate cancer from benign atrophy
MA Farinola et al.
HUMAN PATHOLOGY (2004)
Alpha-methylacyl-CoA racemase: a multi-institutional study of a new prostate cancer marker
Z Jiang et al.
HISTOPATHOLOGY (2004)
Analysis of α-methylacyl-CoA racemase (P504S) expression in high-grade prostatic intraepithelial neoplasia
CL Wu et al.
HUMAN PATHOLOGY (2004)
Prostein expression is highly restricted to normal and malignant prostate tissues
M Kalos et al.
PROSTATE (2004)
P504S immunostaining boosts diagnostic resolution of suspicious foci in prostatic needle biopsy specimens
Z Jiang et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2004)
Fatty acid synthase: A metabolic oncogene in prostate cancer?
A Baron et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2004)
Ki-67 staining index predicts distant metastasis and survival in locally advanced prostate cancer treated with radiotherapy: An analysis of patients in radiation therapy oncology group protocol 86-10
RL Li et al.
CLINICAL CANCER RESEARCH (2004)
Quantitative RARβ2 hypermethylation:: A promising prostate cancer marker
C Jerónimo et al.
CLINICAL CANCER RESEARCH (2004)
Ki-67 staining is a strong predictor of distant metastasis and mortality for men with prostate cancer treated with radiotherapy plus androgen deprivation: Radiation Therapy Oncology Group trial 92-02
A Pollack et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Disease- and cell-specific expression of GP73 in human liver disease
R Iftikhar et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2004)
Expression of NKX3.1 in normal and malignant tissues
EP Gelmann et al.
PROSTATE (2003)
Molecular markers of outcome after radiotherapy in patients with prostate carcinoma - Ki-67, bcl-2, bax, and bcl-x
A Pollack et al.
CANCER (2003)
Basal cell cocktail (34βE12+p63) improves the detection of prostate basal cells
M Zhou et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2003)
The long-term clinical impact of biochemical recurrence of prostate cancer 5 or more years after radical prostatectomy
JF Ward et al.
JOURNAL OF UROLOGY (2003)
Time trends and characteristics of men choosing watchful waiting for initial treatment of localized prostate cancer: Results from CaPSURE
SR Harlan et al.
JOURNAL OF UROLOGY (2003)
Diagnostic utility of immunohistochemical staining for p63, a sensitive marker of prostatic basal cells
MH Weinstein et al.
MODERN PATHOLOGY (2002)
The polycomb group protein EZH2 is involved in progression of prostate cancer
S Varambally et al.
NATURE (2002)
Comparison of the basal cell-specific markers, 34βE12 and p63, in the diagnosis of prostate cancer
RB Shah et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2002)
Can basal cells be seen in adenocarcinoma of the prostate? -: An immunohistochemical study using high molecular weight cytokeratin (clone 34βE12) antibody
BR Oliai et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2002)
Expression of GP73, a resident Golgi membrane protein, in viral and nonviral liver disease
RD Kladney et al.
HEPATOLOGY (2002)
α-methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer
MA Rubin et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Perineural invasion and MIB-1 positivity in addition to gleason score are significant preoperative predictors of progression after radical retropubic prostatectomy for prostate cancer
TJ Sebo et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2002)
Tissue Microarray sampling strategy for prostate cancer biomarker analysis
MA Rubin et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2002)
Gene expression analysis of prostate cancers
JH Luo et al.
MOLECULAR CARCINOGENESIS (2002)
Gene expression correlates of clinical prostate cancer behavior
D Singh et al.
CANCER CELL (2002)
GSTP1 CpG island hypermethylation is responsible for the absence of GSTP1 expression in human prostate cancer cells
XH Lin et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
P504S - A new molecular marker for the detection of prostate carcinoma
Z Jiang et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2001)
Delineation of prognostic biomarkers in prostate cancer
SM Dhanasekaran et al.
NATURE (2001)
Prognostic value of cell cycle proteins p27kip1 and MIB-1, and the cell adhesion protein CD44s in surgically treated patients with prostate cancer
AN Vis et al.
JOURNAL OF UROLOGY (2000)
Minimal adenocarcinoma in prostate needle biopsy tissue
P Thorson et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2000)
p63 is a prostate basal cell marker and is required for prostate development
S Signoretti et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
GP73, a novel Golgi-localized protein upregulated by viral infection
RD Kladney et al.
GENE (2000)
分享论文
